Quarter Change (%) 1/2018 4/2017 1/2017 4/2017 1/2017 Net profit * 9,005 8,496 8,305 6.0% 8.4% Earnings per share (Baht) 4.72 4.45 4.35 6.0% 8.4% Net interest margin 2.34% 2.31% 2.35% 0.03% (0.01)% Net fees
, when including comprehensive loss, had total gain of Baht 99 million. The consolidated net profit for the year 2018 totaled Baht 6,042 million, an increase of 5.3% from Baht 5,737 million in 2017. The
from Asset Management business totaled Baht 801 million. Meanwhile, the Investment business recorded revenue, when including comprehensive loss, had total gain of Baht 99 million. The consolidated net
and the year of 2017: Table: Operating Results (Unit: Million Baht) Items Quarter Variance Quarter Variance For years Variance 4/2018 3/2018 (%QoQ) 4/2017 (%YoY) 2018 2017 (%YoY) Net interest income
the Stock Exchange of Thailand concerning the Acquisition and Disposition of Assets namely 1) the net tangible asset value basis 2) the net profit basis and 3) the total value of consideration basis
1,155.76 million baht which increased by 89.01 million baht or 8.34% from the same period in 2017. The company had the operating profit of 439.23 million baht or 14.22%. For year 2018, net profit of the
115.40% Gross profit margin 61.51% 59.98% 1.53% Net profit margin 45.50% 36.59% 8.91% บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2
shortfall as above mentioned. Net Profit Statements of Financial Position and THB million Y18 Y17 %Chg As Reported (% to Sales) Total Admin Exp. 256(12.4%) 176(12.8%) 45.3% TKS 169(13.4%) 174(12.6%) (3.1
Board 1/2019 on February 25,2019 has been approved the financial statements for year ended 31 December 2018 The Company net profit of 170.42 million baht which decrease 161.95 million baht or (48.72)% by